Spondyloarthritis & psoriatic arthritis
Risk of Mortality of People With Psoriasis and Psoriatic Arthritis in Taiwan: A Nationwide Cohort Study
Main finding · All-cause mortality, after PSMResult — go to the resultAdjusted hazard ratio 1.20 95% CI 1.16–1.24Authors' conclusion
There was an increased risk of all-cause mortality in individuals with PsD compared to individuals without PsD before and after both PSM and adjustment for comorbidities.
Study context
- Population
- Nationwide population-based insurance claim datasets, Taiwan, 2010–2018: patients with incident psoriatic disease (PsD) (40.2% women) and propensity score matching (PSM) non-PsD individualsequal number of PSM controls
- Exposure
- Incident psoriatic disease vs PSM non-PsD individuals
- PsDn = 108,642
- Outcome
- All-cause mortality
Methodological detailsnationwide, population-based, propensity score matching, Cox regression
- Nationwide
- Population-based
- Propensity score matching
- Cox regression
Main finding
All-cause mortality, after PSM
Adjusted hazard ratio
1.20
95% CI 1.16–1.24
PsDvs Non-PsD
aHR 1.20 (95% CI 1.16–1.24)
As reported in the abstract
Observational data: associations, not effects.
Further findings
| Outcome | aHR (95% CI) | P value | |
|---|---|---|---|
| All-cause mortalityvs age- and sex-matched controlsAge- and sex-matched controls | 1.73 (1.68–1.77) | P < 0.001 | |
| 0.512Adjusted hazard ratio (log scale) |
Mortality by biologic therapy exposure and psoriatic arthritis (PsA) (subgroups)
- Trend of higher mortality in patients exposed to biologic therapies, but not for PsA
Original publication
Risk of Mortality of People With Psoriasis and Psoriatic Arthritis in Taiwan: A Nationwide Cohort Study. J Rheumatol. Published 15 February 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →